- 专利标题: Purification of glucose concentration signal in an implantable fluorescence based glucose sensor
-
申请号: US13937871申请日: 2013-07-09
-
公开(公告)号: US09414775B2公开(公告)日: 2016-08-16
- 发明人: Arthur E. Colvin, Jr. , Xiaolin Wang , Colleen Mdingi , Andrew DeHennis
- 申请人: Senseonics, Incorporated
- 申请人地址: US MD Germantown
- 专利权人: Senseonics, Incorporated
- 当前专利权人: Senseonics, Incorporated
- 当前专利权人地址: US MD Germantown
- 代理机构: Rothwell, Figg, Ernst & Manbeck, P.C.
- 主分类号: A61B5/1455
- IPC分类号: A61B5/1455 ; A61B5/145 ; A61B5/1459 ; A61B5/00
摘要:
Methods, sensors, and systems for determining a concentration of glucose in a medium of a living animal are disclosed. Determining the glucose concentration may involve emitting excitation light from a light source to indicator molecules, generating a raw signal indicative of the amount of light received by a photodetector, purifying and normalizing the raw signal, and converting the normalized signal to a glucose concentration. The purification may involve removing noise (e.g., offset and/or distortion) from the raw signal. The purification and normalization may involve tracking the cumulative emission time that the light source has emitted the excitation light and tracking the implant time that has elapsed since the optical sensor was implanted. The purification and normalization may involve measuring the temperature of the sensor. The purification, normalization, and conversion may involve using parameters determined during manufacturing, in vitro testing, and/or in vivo testing.
公开/授权文献
信息查询